David Chen

David Chen invests through AngelVest Group and angel-invests from Shanghai, writing $25k-$100k checks at pre-seed and seed in medical devices and AI/ML in healthcare. AngelVest is a pan-Asia angel network active in China, Hong Kong, and Singapore, which positions him within the structured Asian angel-group ecosystem rather than as a lone-wolf investor. Founders building China-based medical devices, AI-enabled healthcare for Asian markets, or companies that benefit from access to the Greater China healthcare ecosystem are the natural fit. He is the wrong audience for US-only or European-only plays, biotech without an Asia angle, consumer wellness, or anything outside the device-and-AI-software stack. The small check size positions him as an angel-group participant rather than a meaningful individual investor, but AngelVest’s collective network can provide useful Asian go-to-market access for the right founder. Outreach via the AngelVest deal-flow process is the structured channel, with LinkedIn as a secondary path. Warm introductions through AngelVest members, Shanghai healthcare-tech networks, or US-Asia cross-border investor communities help. Given the common name, founders should be careful to verify identity through Crunchbase and AngelVest before reaching out. Best treated as a structured Asian angel-group entry point for the right cross-border healthcare founder.